2025-05-02 22:14:40
Latest Post
Madlab Alpha Pvt Ltd sets out to rewrite the rules of Films & Premium OTT content - one disruptive story at a time 
Diamond Power Infrastructure Ltd receives LOI worth Rs. 71.46 crores
Dixon enters into JV agreement with Inventec
Varun Beverages Ltd approves interim dividend of Rs. 0.50
PVR INOX opens 4 screen multiplex at KA Mall, Jabalpur, Madhya Pradesh
Stock Report
Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 crores
Posted On : 2021-07-27 12:46:07( TIMEZONE : IST )
DR.REDDY'S LABORATORIES LTD. has reported financial results for the period ended June 30, 2021.
Financial Results (Q1 FY 2021-22) - QoQ Comparison
The company has reported total income of Rs.5053 crores during the period ended June 30, 2021 as compared to Rs.4850.8 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.380.4 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.557.3 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.22.89 for the period ended June 30, 2021 as compared to Rs.33.51 for the period ended March 31, 2021.
| Financials | Q1 FY2021-22 | Q4 FY20-21 | % Change |
| Total Income | ₹ 5053 crs | ₹ 4850.8 crs |  4.17% |
| Net Profit | ₹ 380.4 crs | ₹ 557.3 crs |  -31.74% |
| EPS | ₹ 22.89 | ₹ 33.51 | -31.69% |
Financial Results (Q1 FY 2021-22) - YoY Comparison
The company has reported total income of Rs.5053 crores during the period ended June 30, 2021 as compared to Rs.4513.6 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.380.4 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.594.6 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.22.89 for the period ended June 30, 2021 as compared to Rs.35.78 for the period ended June 30, 2020.
| Financials | Q1 FY2021-22 | Q1 FY2020-21 | % Change |
| Total Income | ₹ 5053 crs | ₹ 4513.6 crs | 11.95% |
| Net Profit | ₹ 380.4 crs | ₹ 594.6 crs | -36.02% |
| EPS | ₹ 22.89 | ₹ 35.78 | -36.03% |
Commenting on the results, Co-Chairman & MD, G V Prasad said "The financial performance of the quarter has been driven by healthy sales growth. I am confident about improving our margins in the upcoming quarters which will be led by the scale up of recent launches, new product launches and productivity. While we continue to sharpen execution in our core business, we are also conducting pilots in areas such as Nutrition, Di tamer, and Digital Health & Wellness, which can be future growth drivers."
Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs. 5412.5 as compared to the previous close of Rs. 5422.9. The total number of shares traded during the day was 6992 in over 1587 trades.
The stock hit an intraday high of Rs. 5445.05 and intraday low of 5400.5. The net turnover during the day was Rs. 37922440.
